| Bioactivity | Tepilamide fumarate (XP-23829; PPC-06) is an oral fumaric acid ester, acts as a prodrug of Monomethyl fumarate (HY-103252), and is used in the research of moderate to severe chronic plaque psoriasis[1]. | ||||||||||||
| Name | Tepilamide fumarate | ||||||||||||
| CAS | 1208229-58-6 | ||||||||||||
| Formula | C11H17NO5 | ||||||||||||
| Molar Mass | 243.26 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Mrowietz U, et al. Tepilamide Fumarate (PPC-06) Extended Release Tablets in Patients with Moderate-to-Severe Plaque Psoriasis: Safety and Efficacy Results from the Randomized, Double-blind, Placebo-controlled AFFIRM Study. J Clin Aesthet Dermatol. 2022 Jan;15(1):53-58. |
Tepilamide fumarate
CAS: 1208229-58-6 F: C11H17NO5 W: 243.26
Tepilamide fumarate (XP-23829; PPC-06) is an oral fumaric acid ester, acts as a prodrug of Monomethyl fumarate (HY-10325
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.